YONGTAI TECH.(SZ:002326)2025-04-27 07:41Financial Performance - The company's operating revenue for 2024 was ¥4,589,397,832.70, representing an increase of 11.18% compared to ¥4,128,040,820.94 in 2023[6]. - The net loss attributable to shareholders for 2024 was ¥478,353,981.67, a 22.82% improvement from a loss of ¥619,761,432.13 in 2023[6]. - The net cash flow from operating activities improved by 66.31%, reaching -¥110,869,010.36 in 2024 compared to -¥329,126,584.00 in 2023[6]. - The basic and diluted earnings per share improved to -¥0.52 in 2024 from -¥0.69 in 2023, reflecting a 24.64% increase[6]. - Total assets decreased by 1.88% to ¥11,190,303,037.06 at the end of 2024 from ¥11,404,306,777.82 at the end of 2023[6]. - The net assets attributable to shareholders decreased by 15.54% to ¥2,671,269,113.39 at the end of 2024 from ¥3,162,895,712.22 at the end of 2023[6]. - The total revenue for 2024 reached ¥4,589,397,832.70, representing an 11.18% increase from ¥4,128,040,820.94 in 2023[67]. - The industrial segment contributed ¥3,184,565,011.65, accounting for 69.39% of total revenue, with a year-on-year growth of 23.55%[67]. - The agricultural protection segment saw a significant increase of 91.79%, generating ¥1,029,494,398.50 in revenue[67]. - The lithium battery and other materials segment reported revenue of ¥1,021,411,381.42, reflecting an 18.07% increase year-on-year[67]. Business Strategy and Operations - The company plans not to distribute cash dividends, issue bonus shares, or increase capital using reserves[4]. - The company aims to expand its international market presence and promote the internationalization of its formulations in the pharmaceutical sector[26]. - The company is focusing on vertical integration from intermediates and raw materials to formulations to enhance profitability and stability in the pharmaceutical segment[26]. - The company plans to optimize its product structure and enhance technological innovation to improve competitiveness in the lithium battery materials sector[25]. - The company has established a vertically integrated industrial chain in the plant protection sector, covering intermediates, raw materials, and formulations, aiming to enhance technical capabilities and reduce costs[27]. - The company is currently constructing projects related to pharmaceutical intermediates, pesticides, and lithium battery materials[94]. - The company has established multiple production bases across regions including Zhejiang, Inner Mongolia, Fujian, and Guangdong to support future core business growth[56]. - The company is actively registering and applying for new products to expand its product portfolio and enhance sales capabilities in the pharmaceutical sector[107]. - The company plans to invest ¥174.43 million in projects in 2024, with a remaining balance of ¥172.48 million in raised funds as of December 31, 2024[102]. Research and Development - The company has multiple innovation technology platforms and a specialized R&D team, holding numerous leading technology patents[51]. - R&D investment totaled 140,378,251.46 CNY, representing 3.06% of total revenue, down from 4.12% in the previous year[81]. - The number of R&D personnel decreased by 11.45% to 464, with a notable increase in the proportion of master's and doctoral degree holders[80]. - The company is currently in the pilot production phase for new lithium battery materials aimed at improving battery performance and stability[80]. - The company has multiple patented technologies, including those for intermediates and pharmaceutical products, enhancing its competitive edge in the market[46]. Environmental Compliance and Sustainability - The company has established a comprehensive environmental protection regulatory framework, regularly updating compliance with applicable laws[176]. - The company is classified as a key pollutant discharge unit by environmental protection authorities[176]. - The company has implemented measures to ensure compliance with major environmental protection laws, including the Environmental Protection Law and the Air Pollution Prevention Law[177]. - The company has a pollution discharge permit for 永太科技 valid until March 28, 2029[178]. - The company has reported a COD discharge of 42.334 mg/L, exceeding the standard limit of 500 mg/L[180]. - The company is actively monitoring and managing its emissions to adhere to environmental regulations[180]. - The company has committed to ongoing compliance with national and local environmental standards to mitigate pollution[181]. - The company invested CNY 92.104 million in environmental governance and protection in 2024, and paid CNY 98,000 in environmental protection tax[193]. Corporate Governance - The company has established a complete governance structure in compliance with relevant laws and regulations, ensuring effective operation and management[122]. - The board of directors consists of 9 members, including 3 independent directors, with 44% of board members being female, including the chairperson and CFO[123]. - The company has a complete and independent financial management system, with dedicated financial personnel and independent accounting practices[128]. - The company actively respects and protects the rights of stakeholders, balancing interests among shareholders, employees, and society[127]. - The company has implemented a diversified policy for its board of directors, considering various factors such as gender, age, and professional experience[123]. - The company ensures timely and accurate information disclosure to all shareholders, providing equal access to information[124]. - The company has established a performance evaluation and incentive mechanism for directors, supervisors, and senior management, ensuring transparency and compliance with regulations[124]. - The company has not experienced any significant discrepancies between its governance practices and the regulations set forth by the China Securities Regulatory Commission[126]. Employee Management - The total number of employees at the end of the reporting period is 3,467, with 933 in the parent company and 2,534 in major subsidiaries[159]. - The employee composition includes 1,673 production personnel, 253 sales personnel, 740 technical personnel, 65 financial personnel, and 736 administrative personnel[159]. - The company has a clear compensation policy linking employee income to performance and capabilities, aimed at motivating staff[160]. - The company has a training program focused on enhancing employees' skills and overall competitiveness to align with its strategic goals[161]. - The company has confirmed that there are no retired employees requiring financial support, indicating a streamlined workforce[159]. Shareholder Relations - The company has established a three-year shareholder return plan (2024-2026) to ensure the continuity and stability of its profit distribution policy[162]. - The company has not received any objections regarding the restricted stock incentive plan from the supervisory board or other stakeholders[165]. - The company completed the registration of the 2024 restricted stock incentive plan, with a total of 11,640,000 shares granted to 302 participants[167]. - The company has a structured remuneration decision-making process based on performance and industry standards[147]. - The company has established a performance assessment mechanism for senior management under the 2024 restricted stock incentive plan, aligning with industry compensation levels and annual operational goals[169].